<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Transforming growth factor (TGF)-beta family members are multifunctional cytokines that elicit their effects on cells, including endothelial and mural cells, via specific type I and type II serine/threonine kinase receptors and intracellular Smad transcription factors </plain></SENT>
<SENT sid="1" pm="."><plain>Knock-out mouse models for TGF-beta family signaling pathway components have revealed their critical importance in proper yolk sac <z:mpath ids='MPATH_177'>angiogenesis</z:mpath> </plain></SENT>
<SENT sid="2" pm="."><plain>Genetic studies in humans have linked mutations in these signaling components to specific cardiovascular syndromes such as hereditary hemorrhagic <z:hpo ids='HP_0001009'>telangiectasia</z:hpo>, primary <z:hpo ids='HP_0002092'>pulmonary hypertension</z:hpo> and <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>In this review, we present recent advances in our understanding of the role of TGF-beta receptor signaling in vascular biology and disease, and discuss how this may be applied for therapy </plain></SENT>
</text></document>